Cargando…
ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer
The RAF/MEK/ERK signaling pathway regulates diverse cellular processes as exemplified by cell proliferation, differentiation, motility, and survival. Activation of ERK1/2 generally promotes cell proliferation, and its deregulated activity is a hallmark of many cancers. Therefore, components and regu...
Autores principales: | Sugiura, Reiko, Satoh, Ryosuke, Takasaki, Teruaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533760/ https://www.ncbi.nlm.nih.gov/pubmed/34685488 http://dx.doi.org/10.3390/cells10102509 |
Ejemplares similares
-
ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells
por: Khandakar, Golam Iftakhar, et al.
Publicado: (2022) -
More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis
por: Takasaki, Teruaki, et al.
Publicado: (2018) -
Apoptosis, A Double-Edge Sword!
por: Rossello, Xavier, et al.
Publicado: (2017) -
Reply: Apoptosis, A Double-Edge Sword!
por: Weil, Brian R., et al.
Publicado: (2017) -
Redox regulation in cancer: A double-edged sword with therapeutic potential
por: Acharya, Asha, et al.
Publicado: (2010)